The Asia Pacific compound management market is expected to reach US$ 167.94 Mn in 2027 from US$ 50.78 Mn in 2018. This market is projected to grow at a growth rate of 14.9% from 2019-2027.
The growth of the compound management market is primarily attributed to rising drug discovery activity in the Asian countries and initiatives undertaken by the government bodies. On the other hand, growth opportunities in developing countries is expected to have a positive effect on the growth of the Asia Pacific compound management market in the coming years.
Asian countries, such as South Korea, India, China, Japan, among others, have witnessed growth in the geriatric population, which is more susceptible to chronic illnesses. The increasing prevalence of chronic medical conditions has led to an alarming need for the discovery of efficient drugs for the treatment of these conditions. The process of drug development is lengthy, costly, and has a high degree of improbability that a drug will succeed. Drug discovery aims to relate the operation of a compound to its chemical structure and therefore is used to identify more active compounds. Various Asian countries have adopted modern technologies that can help in the efficient development of new drugs. For instance, Governments of South Korea is focusing on the development of artificial intelligence (AI) based drug discovery. In 2019 the Korean Government announced to fund US$ 21.7 Million for growth and innovation of effective medicines using artificial intelligence (AI).
Asia Pacific compound management market is segmented by product & services, sample type, application, and end user. Based on product & services the market is categorized as, compound/sample management products and services. The market is classified based on sample type such as, chemical compounds and biosamples. On the basis of application, the market is categorized as, drug discovery, gene synthesis, and biobanking. Similarly, as per end user, the compound management market is segmented as, pharmaceutical companies, biopharmaceutical companies, contract research organizations (CROs), and others.
Some of the major primary and secondary sources for compound management included in the report are World Health Organization (WHO), National Centre for Biological Sciences (NCBS), Food and Drug Administration (FDA), and Council of Scientific and Industrial Research (CISR) among others.
Reasons to Buy
The growth of the compound management market is primarily attributed to rising drug discovery activity in the Asian countries and initiatives undertaken by the government bodies. On the other hand, growth opportunities in developing countries is expected to have a positive effect on the growth of the Asia Pacific compound management market in the coming years.
Asian countries, such as South Korea, India, China, Japan, among others, have witnessed growth in the geriatric population, which is more susceptible to chronic illnesses. The increasing prevalence of chronic medical conditions has led to an alarming need for the discovery of efficient drugs for the treatment of these conditions. The process of drug development is lengthy, costly, and has a high degree of improbability that a drug will succeed. Drug discovery aims to relate the operation of a compound to its chemical structure and therefore is used to identify more active compounds. Various Asian countries have adopted modern technologies that can help in the efficient development of new drugs. For instance, Governments of South Korea is focusing on the development of artificial intelligence (AI) based drug discovery. In 2019 the Korean Government announced to fund US$ 21.7 Million for growth and innovation of effective medicines using artificial intelligence (AI).
Asia Pacific compound management market is segmented by product & services, sample type, application, and end user. Based on product & services the market is categorized as, compound/sample management products and services. The market is classified based on sample type such as, chemical compounds and biosamples. On the basis of application, the market is categorized as, drug discovery, gene synthesis, and biobanking. Similarly, as per end user, the compound management market is segmented as, pharmaceutical companies, biopharmaceutical companies, contract research organizations (CROs), and others.
Some of the major primary and secondary sources for compound management included in the report are World Health Organization (WHO), National Centre for Biological Sciences (NCBS), Food and Drug Administration (FDA), and Council of Scientific and Industrial Research (CISR) among others.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the compound management market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the compound management market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Asia Pacific Compound Management Market - Market Landscape
4. Asia Pacific Compound Management Market - Key Market Dynamics
5. Compound Management Market - Asia Pacific Analysis
6. Asia Pacific Compound Management Market Analysis - By Product & Services
7. Asia Pacific Compound Management Market Analysis - By Sample Type
8. Asia Pacific Compound Management Market Analysis - By Application
9. Asia Pacific Compound Management Market Analysis - By End User
10. Asia Pacific Compound Management Market Revenue and Forecasts To 2027
11. Compound Management Market - Industry Landscape
12. Compound Management Market-Key Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biosero Inc.
- Meridian Bioscience
- Evotec
- Icagen, Inc.
- TCG Lifesciences Pvt. Ltd.
- TTP Labtech
- Frontier Scientific Services
- Hamilton Company
- Tecan Trading AG
- Brooks Life Sciences